Recent Financings of Private Companies (09/11)
This article was originally published in Start Up
Executive Summary
Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.
You may also be interested in...
FDA Considers New Regulatory Pathways For Some Cellular Products
The US agency is re-evaluating its criteria for certain human cells, tissues and cellular and tissue-based products (HCT/Ps) that are not ideally regulated as BLAs. A 2014 guidance on cord blood products could serve a template, industry suggests.
CEO Snapshots From The MedTech Forum
Among the highlights of MedTech Europe’s annual MedTech Forum are the “unfiltered” views offered by company CEOs on the entire range of issues that influence decision-making or will have an impact on business operations in the near term.
Snapshot: May Highlights
A selection of articles you might have missed from May 2022, including exclusive interviews, an in depth discussion about China's rise to become one of the world's leaders in R&D, and the latest Rising Leaders interviews.